doctor

Andrea Burnett-Hartman, PhD, MPH, BPH

Dr. Burnett-Hartman's research focuses on understanding factors associated with colorectal cancer, precursor lesions, and colorectal cancer screening. Her current research is aimed at understanding the clinical importance of subsets of serrated polyps, with the ultimate goal of defining the risk of colorectal cancer in those with different types of serrated polyps and improving the effectiveness of colorectal cancer screening and surveillance. She is also a co-investigator at the coordinating center for the NIH-sponsored multi-site initiative, Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) Colorectal Working Group and in Kaiser Permanente’s Research Bank initiative. In collaboration with researchers at the University of Washington, Dr. Burnett-Hartman is also working to develop, and test, protocols for using biomedical informatics to extract data from electronic medical records.



NIH U01 CA163304 (Co-PIs: Feng/Barlow) 09/20/11 – 09/19/16
PROSPR Statistical Coordinating Center (PSCC)
The goal of the PROSPR Statistical Coordinating Center (PPSCC) is to coordinate the research of PROSPR Research Centers (PRCs) to achieve PROSPR’s mission of evaluating and improving the cancer screening process (recruitment, screening, diagnosis, and referral for treatment).
Role: Co-Investigator

Kaiser Foundation Health Plan (PI: Emmons) 01/05/15-12/31/17                
KP National Research Bank
The KP National Research Bank is a collaboration across all Kaiser regions nationally funded by Kaiser Foundation Health Plan.  The goal of the KP National Research Bank is to collect blood samples from 500,000 adult KP members and utilize them, combined with survey data and medical information to create a state of the art resource for genetic and health services research.
Role: Co-Investigator

NIH R03 CA186215 (PI: Burnett-Hartman) 04/01/14 – 03/31/16
Using Medical Informatics to Follow-up a Sessile Serrated Polyp Cohort
This proposal will use the University of Washington’s data aggregation platform to identify a cohort of over 750 patients diagnosed with sessile serrated polyps from 2003-2011 and follow these patients up for colorectal cancer via linkage with the Puget Sound Surveillance Epidemiology and End Results Cancer Registry.
Role: Principal Investigator

NIH R01 CA168338 (PI: Newcomb) 4/22/13-3/31/17
A Cohort Study of Sessile Serrated Polyps and Subsequent Colorectal Neoplasia
Recent evidence implicates an additional group of polyps, sessile serrated polyps, as potential precursors to a subset of colorectal cancer. This project will investigate the clinical significance of sessile serrated polyps, with the long-term goal of identifying new groups that are high-risk for colorectal cancer and improving the effectiveness of colorectal cancer screening.
Role: Co-Investigator

View a comprehensive list of Dr. Burnett-Hartman's publications here.